Sector: Life Sciences / Genetics
Location: Oxford, United Kingdom
Business Overview
- Genetic analysis of new drug molecules for Big Pharma companies to identify genetic mutations that mimic effect of drugs on proteins
- Allows early triage of drugs that likely won’t work or likely to cause side effects; at least doubles chance of early identification of drugs that likely will work or can tackle other diseases
